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Summary 
Most current models of T  cell development include a positive selection step in the thymus that 
occurs when T cells interact with thymic epithelium and a negative selection step after encounters 
with bone marrow-derived cells. We show here that developing T cells are tolerized when they 
recognize antigens expressed by thymic epithelium,  that the tolerance is tissue specific,  and that 
it  can occur by deletion of the reactive T  cells. 
I 
't is generally believed that the primary role of the thymic 
. epithelium  (TE) 1 is to serve as an environment  in which 
T  cell precursors differentiate into mature T  cells, as well as 
to selectively promote maturation  of those T  cells  deemed 
to be "useful" by virtue of their affinity for self-MHC mole- 
cules. Although the question of whether cells of the thymic 
stroma also play a role in the induction of tolerance has been 
asked several times, the results have been diffcult to fit into 
any clear model. Using several different approaches and a va- 
riety of antigens,  some groups have reported that  TE does 
not generate tolerance (1),  whereas others have found that 
it does. Among the latter,  some have found that T cells spedfic 
for antigens  presented by the TE are deleted (2,  3),  while 
some report only partial deletion (4-6).  Others have found 
anergy (7) or a form of split tolerance in which the T  cells 
react  in vitro but  not  in  vivo (8-10). 
Several hypotheses have been put forward to explain these 
results.  It has been suggested that  TE  induces deletion  of 
high aff￿  but not low affinity T  cells (3,  11), that it in- 
duces a form of partial  anergy (7), or that  it establishes an 
immunological network that maintains tolerance in vivo but 
is disrupted in vitro (8).  To incorporate positive as well as 
negative selection, it has also been suggested that the TE is 
composed of two sorts of tissues that  express different an- 
tigens, one that positively selects and one that induces toler- 
ance  (5). 
Here we have tested another possibility. Starting with the 
assumption that the response against MHC molecules is ac- 
tually directed against a panoply of MHC-peptide complexes 
(12,  13), that the peptides complexed with MHC molecules 
are derived from normal cellular proteins  (14-16),  and that 
different tissues, because of their different functions,  might 
well express different arrays  of proteins,  we concluded that 
each tissue should display its own unique pattern of MHC- 
peptide  complexes,  which  we call  a MAP  (MHC  antigen 
1 Abbreviations  used in thispaper: MAP, MHC antigen profile; TE, thymic 
epithelium; Tg, transgenic;  "IS, thymic stroma. 
profile). We reasoned that if the TE induces tolerance, it would 
naturally tolerize only for the MHC-peptide complexes in- 
cluded in its own surface MAP,  sparing  T  cells capable of 
responding to the MAPs of other tissues.  Since the strength 
of the response against  any particular  tissue would depend 
on how its MAP overlapped with the MAP of the TE, many 
of the reported cases of split tolerance induced by TE might 
actually be unrecognized  cases  of tissue-specific tolerance. 
To test this view, we reexamined the tolerogenic capability 
of TE using two sorts of transplantation antigens: allogeneic 
MHC molecules and the minor transplantation  antigen H-Y. 
We chose these two antigens because: (a) both are intrinsi- 
caUy expressed by thymic epithelium; (b) both elicit responses 
from CD4 + as well as CD8 + T  cells;  (c) reactivity to both 
can be assessed by in vivo as well as in vitro tests;  and (d) 
male bone marrow-derived cells are able to tolerize for male 
skin (17). We thought it likely therefore that H-Y would con- 
sist of one or at most a small set of peptide-MHC complexes 
shared by the surface MAPs of many tissues, whereas aUogeneic 
MHC would consist  of a large set of MHC-peptide  com- 
plexes that vary from tissue to tissue. We found that the con- 
cept of tissue-specific tolerance does indeed account for the 
previously reported variety in the tolerogenic behavior of TE. 
Materials  and  Methods 
Mice 
C57BL/6 (B6), BALB/c, nudes of both strains, as well as het- 
erozygous litter mates, AKR, and timed pregnant  mice were pur- 
chased from the Frederick Animal Facility (National Cancer Insti- 
tute,  National  Institutes  of Health,  Frederick, MD). H-Y TCR 
transgenic mice (18) were bred at our colony (Bioqual, Gaithers- 
burg,  MD) onto the B10 and B10.A backgrounds. 
Thymic  Stroma (TS) 
Thymuses from fetal (14 d, with day of plug  =  0) male or fe- 
male B6 or BALB/c mice were cultured for 5-7 d in transwell cul- 
ture plates (Costar, Cambridge, MA) with 1.35 mM deoxyguano- 
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washed and transplanted into recipient mice. The thymic rudiment 
that remains after deoxyguanosine treatment contains TE and a 
small number of macrophages (20). These macrophages are not 
competent professional  APC in that they do not initiate rejection 
of the TE in fully allogeneic recipients (21), nor do they appear 
to induce tolerance to the MHC they express (1). Evidence that 
the treatment effectively  removed professional APC comes from 
Figs. 3 and 6, where we found that B6 male or female  deoxy-treated 
thymuses transplanted  into BALB/c  nude mice did not impart toler- 
ance to B6 APC, whether the tests were done in vitro by MLR 
or in vivo by the rejection of B6 splenic fragments. We will refer 
to these grafted thymic rudiments as TS. 
Thymus-transplanted Chimeras 
All chimeras were created by transplanting TS (four to five 
thymuses) under the left kidney capsule of adult animals as previ- 
ously described (1). For the experiments depicted  in Fig. 1, B6 male 
or female TS was grafted into female B6 nude mice. For Figs. 2 
and 3, B6 male or female TS was grafted into B10.A (H-2  ~) trans- 
genic (Tg) recipients carrying the anti-H-Y TCR. For Figs. 4-9, 
B6 or BALB/c  TS was grafted into female  BALB/c  nude mice. The 
chimeras were used after a minimum of 6 (transgenic recipients) 
or 8 wk (nude recipients). 
In  Vitro Assays 
Medium and Supplements.  All in vitro cultures were set up in 
IMDM containing 10% FCS, 5  x  10 -s M B-mercaptoethanol, 
and 50 #g/ml gentamycin. 
Mixed Leukocyte Reaction (MLR).  Splenic  responder cells were 
panned on anti-IgM- (10 #g/ml; Southern Biotechnologies As- 
sociates, Birmingham, AL) and anti-Ia- (14.4.4, purified in our lab- 
oratory; 10 #g/ml) coated plates to remove B- and h-positive cells 
and plated at the indicated  concentrations in 96-well, flat-bottomed 
plates (Costar, Cambridge, MA) with 4  x  10  s -y-irradiated  (2,000 
rad) stimulator spleen cells/well. After 4 d, cultures were pulsed 
with 1/~Ci/well [3H]thymidine, harvested 18 hours later on a 96 
well harvester (Brandell, Gaithersburg, MD),  and counted on a 
B counter (B plate, 1205; Pharmacia, LKB, Gaithersburg, MD). 
Data are shown as Acpm. 
Cytotoxic Assays (CTL).  4  x  106 spleen responder cells per 
2-ml well were cultured for 5 d with 2  x  106 splenic irradiated 
stimulator cells in 24-well plates (Costar), after which they were 
harvested and tested for CTL activity using the JAM Test (22), 
an assay that measures CTL activity by DNA degradation rather 
than membrane integrity. Briefly, the targets were Con A (2.0 
#g/ml; Sigma Chemical Co.) blasts, pulsed after 36 h of culture 
for 8 h with [3H]TdR. The blasts were washed, plated at  104 
target cells/well in round-bottomed 96-well plates (Costar) that 
contained titrated numbers of the responder population. After 3 h, 
the plates were harvested as described for the MLKs. Percent spe- 
cific killing was calculated as: 100  x  spontaneous DNA retention 
(cpm)  -  experimental DNA retention (cpm)Apontaneous DNA 
retention  (cpm); where spontaneous retention  is the  [3H]TdR- 
labeled DNA obtained from targets incubated without killers, and 
experimental retention is the  [3H]TdK obtained in the cultures 
containing both targets and responder cells. 
In  Vivo Assays 
Skin Grafts.  Animals  were grafted on the dorsal thorax with 
tail skin. The grafts were sutured to keep them in place until com- 
plete healing was achieved. They were protected with a surgical 
bandage that was removed after 6 d, and inspected then and every 
2 d thereafter. Primary and secondary skin grafts were performed 
similarly. 
Spleen Grafts.  3-5-mm fragments of the indicated spleens were 
obtained by compressing the capsule and cutting at the compres- 
sion line. These small "pillows" of spleen were then grafted under 
the kidney capsule  of the recipients. They were examined  after 21 d. 
Untreated Thymus Grafts.  Four thymus lobes from 15-d-old B6 
fetuses were grafted under the right kidney capsule of each host 
and analyzed  at various times later by visual  inspection, cell counts, 
and FACS  |  analysis  (Becton  Dickinson  & Co., Mountain View, CA). 
Cytofluorimetry.  Cells from grafted thymuses were counted, 
washed, and stained with the following mAbs: either anti-D a or 
Kb-FITC (Pharmingen, San Diego, CA), plus CD8-red 613 (Gibco 
BILL, Gaithersburg, MD) and CD4-PE (Pharmingen), or T3.70- 
biotin (23), CD8-red 613 and CD4-FITC (Pharmingen), followed 
by a wash and streptavidin-PE (Pharmingen). They were analyzed 
on a FACScan  |  flowcytometer  using FACScan  |  Research software 
(Becton Dickinson & Co.). 
Results 
Testing the Tolerogenic Capacity of TS in Nude Recipient Mice. 
To see whether H-Y presented by TS would induce tolerance 
to other male tissues, we treated male and female C57BL/6 
(B6) fetal thymuses with deoxyguanosine to remove the bone 
marrow-derived cells, grafted the resulting TS into B6 fe- 
male nudes, and tested these chimeric animals in vivo and 
in vitro for tolerance  to B6  male and female tissues. 
2 mo after thymus grafting, the chimeras were immunized 
intraperitoneally with 2  x  106 B6 male spleen cells. They 
were grafted 2 wk later with B6 male, B6 female,  and al- 
logeneic AKK skin, and tested for CTL activity 30 d after 
rejection of the AKK skin. Fig.  1 shows that nudes grafted 
with male TS did not generate CTL specific for male targets 
or reject male skin, whereas nudes grafted with female TS 
generally responded as well as control B6 females in both 
of these tests,  and all the animals responded to third-party 
AKK. Thus, by both in vivo and in vitro tests,  we found 
that male TS induced tolerance to other male tissues. 
Although this finding was suggestive of the tolerogenic 
capacity of deoxy-treated TS, it was not definitive. Since both 
the TS and the recipients  were H-2  b, the intact H-Y mole- 
cule might have been transferred to host dendritic cells, which 
would then have processed the molecule and presented it to 
tolerize immature T  cells in the grafted thymus (24).  We 
therefore retested the tolerizing capacity of TS in two situa- 
tions designed to circumvent the activity of  bone marrow-de- 
rived APC. 
Testing the Tolerogenic  Capacity of TS in Transgenic  Mice  Our 
first approach was to graft B6 male or female TS into H-2  a 
mice transgenic for an anti-H-Y TCK. This TCK, distin- 
guished by the mAb T3.70,  was originally cloned from a 
CD8 + T cell clone isolated from a B6 female mouse. It uses 
the MHC D b molecule as a restriction element and cannot 
recognize H-Y complexed with H-2  ~ (25).  Under normal 
conditions in H-2  b female thymuses (such as B6),  T3.70 + 
T cells develop nicely, forming plump thymuses that contain 
a large proportion of T3.70 + CD8 + single-positive cells (23, 
25).  However, in male H-2  b mice the T3.70 + T  cells are 
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Figure  1.  Chimeras reconstituted 
with male TS are tolerant to H-Y 
in both in vivo and in vitro tests. 
Individual  B6  female  nude  mice 
were grafted with B6 female (top) 
or male TS (bottom), primed to H-Y 
after 8 wk and tested 14 d later for 
skin graft rejection (right) and 30 d 
later for CTL (left)  responses against 
B6 male, B6 female, and allogeneic 
AKR targets and skin. The dashed 
lines in the CTL tests represent the 
CTL activity of a normal B6 female 
mouse primed at the same time as 
the chimeras. 
deleted at an early stage of development (26). These severely 
depleted  thymuses  contain  an  overabundance  of double- 
negative T  cells,  and few CD8 + single-positive T  cells car- 
rying T3.70.  In contrast, H-2  ~ mice (such as B10.A) express 
no H-Y/D  b deleting or selecting elements recognizable by 
the T3.70  TCR.  Therefore,  the transgenic  T  cells  do not 
develop and the thymuses produce and export T cells bearing 
endogenous receptors. In the B6 TS --~ BIO.A Tg chimeras, 
the only tissue able to present  H-Y with D b is the grafted 
H-2  b stroma.  Thus,  even if H-2  ~ dendritic  cells  from  the 
B10.A hosts were able to capture the H-Y antigen from the 
male B6 TS and represent it (24), T3.70 § T cells would not 
recognize the H-Y/H-2 a complexes. Therefore, any positive 
or negative selection events in these thymuses must be due 
to recognition of H-Y/D  b complexes on the transplanted TS 
itself. 
We used  the  two  well-established  criteria,  thymus  cell 
number  and T  cell phenotype,  to assess the effect of male 
and female B6 TS on the development of the Tg T3.70 § T 
cells  in  male  and  female  H-2  ~ hosts.  Fig.  2  shows  the 
numbers  of thymocytes  present  in  the  grafts  6  wk  after 
grafting.  Female TS grafts were well repopulated,  ranging 
from 1 to 5  x  107 cells,  and contained on average  200-fold 
more T  cells  than  male TS grafts,  which ranged  from 0.2 
to 20  x  104 cells/graft. Female grafts transplanted into male 
recipients  (an excellent source of potentially reprocessable H-Y) 
were slightly smaller than those grafted into female bodies, 
indicating  that  the cells  of the TS may be able to pick up 
and present a certain amount of H-Y to induce a small amount 
of deletion.  However, the massive deletion that  is seen in 
"normal" B6 male transgenic mice was only seen in chimeras 
in which the TS itself intrinsically expressed the H-Y antigen. 
Using the mAb T3.70 to identify the cells expressing the 
transgenic TCR, we analyzed the specificity of the depletion 
induced by male TS.  Fig.  3 illustrates  the CD4  and CD8 
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staining patterns of thymocytes expressing T3.70 in "normal" 
transgenic  (Tg)  (H-2  ~  x  H-2b)F,  mice  and  in  B6  TS  -~ 
B10.A  transgenic  chimeras.  In  the  F1  transgenics,  where 
both selecting and nonselecting MHC types are present, the 
thymuses of female mice (Fig.  3 a) allow the differentiation 
of large numbers of CD8 + cells expressing high levels of the 
transgenic TCR.  In contrast,  there are virtually no TCR + 
CD8 § cells among the few cells remaining  in a typical F1 
male transgenic (Fig. 3 b). Fig. 3, c and d, represent the profiles 
of two mice from Fig. 2, showing that cells from the female 
or male H-2  b TS grafted into male H-2  ~ mice are virtually 
indistinguishable  from those of the control transgenics.  B6 
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Figure  2.  Male TS induces severe depletion of thymocyte populations 
in H-2  = anti-H-Y transgenic mice. Male or female B6 TS grafts were trans- 
planted into intact H-2  a male or female anti-H-Y transgenic mice. 6 wk 
after grafting, the total number of lymphoid cells in each transplanted 
thymus was  counted. a  female Tg  thymus  b  male Tg  thymus 
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Figure  3.  Male TS induces deletion of H-Y-specific transgenic T cells. 
Comparison of the CD4 and CD8 staining patterns of H-2  a TCR T3.70  hi 
thymocytes found in B6 female (c) and male (d) TS grafted into male B10.A 
transgenic recipients with those of T3.70 hi thymocytes found in normal 
(H-2'  x  H-2b)F1  female (a)  and male (b)  transgenic  thymus. 
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Figure  4.  Neither B6 female nor B6 male TS tolerizes BALB/c nude 
recipients for acceptance of B6 skin grafts. Eight B6 female and eight B6 
male B6 TS ~  BALB/c nude chimeric animals were primed with 2  x 
106 B6 male spleen cells.  3 wk later they were grafted with B6 female, 
B6 male, and AKR tail skin and examined 1 wk later and every 2 d thereafter. 
female TS (Fig. 3 c) allows the differentiation of large numbers 
of CD8 + TCR + cells,  whereas the very few surviving T 
cells in B6 male TS (Fig.  3 d) are mostly double negative. 
Thus,  B6  male  TS  induces  deletion  of T3.70 +  T  cells, 
whereas female TS does not, even in an environment where 
H-Y is expressed by the bone marrow-derived cells migrating 
into the thymus. 
We concluded that TS has the ability to present its own 
antigens to tolerize immature CD8 T cells and that, at least 
in the case of H-Y, it does so by inducing deletion of the 
reactive cells. 
Testing the Tolerogenic Capacity of Male B6 TS in BALB/c 
Nude Recipients.  The transgenic mice had allowed us to assess 
tolerance by visual phenotyping of cells bearing a single TCK. 
To look at functional, whole-body tolerance, we grafted male 
or female B6 TS into female BALB/c nude recipients and 
grafted them with male and female B6 skin. Here again the 
reprocessing of H-Y by the H-2  d host APC should not affect 
T  cells able to recognize H-Y with H-2  b class I or class II 
molecules, and any tolerance induced to B6 male tissues should 
be due only to  the TS itself.  Based  on published reports 
showing that TS-grafted chimeras accept skin of the thymic 
type (8, 9), we predicted that B6 female TS would tolerize 
only for female B6 skin and that B6 male TS should tolerize 
for both female and male B6 skin. The results were surprising. 
3 mo after grafting the TS, we immunized the chimeras 
with B6 male spleen cells and 2 wk later grafted them with 
B6 male, B6 female, and BALB/c skin. To our great surprise 
(Fig.  4), both male and female B6 skin grafts were rapidly 
rejected, regardless of the sex of the grafted thymus. It seemed 
that neither the female nor the male B6 thymuses had in- 
duced tolerance. 
In the earlier reports, the TS-grafted recipients that had 
accepted thymic type skin had not been immunized before 
skin grafting (8,  9).  We therefore repeated our tests with 
a second set of B6 TS ~  BALB/c nude chimeras that were 
not primed before grafting. Fig. 5 a shows that the primary 
skin grafts were accepted. However, using the standards set 
by Billingham et al. (27),  we saw that they were not abso- 
lutely healthy, being slightly swollen and not covered with 
luxurious tufts of hair.  When regrafted, the same animals 
rapidly rejected the second grafts (Fig. 5 b). Thus, it seemed 
that the chimeras had achieved a certain level of tolerance to 
B6 skin antigens, enough to allow tentative survival of the 
primary grafts but not enough to allow graft acceptance in 
primed animals. 
B6  TS  Does Not  Tolerize T  Cells Specific for B6 Spleen, 
whether Tested In Vivo or In Vitro.  The pattern of skin graft 
rejection seen  in the B6  TS -~ BALB/c nude chimeras is 
similar to that sometimes seen when recipient and graft differ 
by certain weak minor histocompatibility antigens, and is 
consistent with the notion that the surface MAPs of skin 
and TS are strikingly alike but that enough differences re- 
main to serve as targets for a primed immune system. Neverthe- 
less, many groups have reported discrepancies between in vivo 
and in vitro assays of the tolerant state in thymus grafted 
chimeras (3, 9-11), and it has been suggested that the tolerant 
state induced by TE may be "fragile" and easily perturbed, 
e.g., by culturing the cells in vitro (8, 10) or perhaps by im- 
munization of low affinity ceils (3).  We therefore tested a 
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Figure 5.  B6 TS ~  BALB/c nude chimeras accept primary but not sec- 
ondary B6 skin grafts. (a) 16 unprimed chimeric animals were grafted on 
the dorsal thorax with B6, BALB/c, and B10.A tail skin and examined 
1 wk later and every 2 d thereafter. (b) 55 d after the primary graft they 
were regrafted with B6 and BALB/c skin and examined as for the primary 
grafts. The primary BALB/c grafts remained intact for >120 d. The pri- 
mary B6 grafts went through a rejection crisis at the same time as the 
secondary grafts and emerged from this reduced in size. 
set of unprimed B6 TS ~  BALB/c nude chimeras against 
other tissue antigens, using both in vivo and in vitro assays. 
As was previously reported, we found that unprimed B6 
TS --,- BALB/c nude chimeras generated both CTL and MLK 
responses to B6 spleen stimulators (Fig. 6). The chimeras were 
tolerant of BALB/c, and responded 3-30-fold less well to B6 
than to third-party AKR cells. Thus, by titrated in vitro tests, 
it appeared that B6 TS induced a substantial reduction in the 
response to B6 spleen cells though it did not produce a state 
of complete tolerance. 
To compare the in vivo and in vitro responses to the same 
tissue, we grafted small "pillows" of intact spleen from B6 
nude or BALB/c nude mice (to avoid a GVH reaction) under 
the kidney capsules of our experimental chimeras and, as a 
control, also into nude chimeras that had been reconstituted 
with BALB/c  TS. Fig. 7 shows that B6 TS --~ BALB/c  chimeras 
were as responsive to B6 spleen antigens in vivo as they were 
in vitro.  By macroscopic examination (Fig. 7 A), we found 
that both the control (left pair) and experimental (right pair) 
mice rejected B6 spleen grafts within 3 wk and retained syn- 
geneic BALB/c spleen grafts in perfect condition for at least 
2 mo. Examination of tissue sections showed that the rejec- 
tion of  B6 spleen by experimental B6 TS ~  BALB/c chimeras 
was slightly less vigorous  than by control BALB/c TS -~ 
BALB/c mice. Fig. 7 B shows the typical structure of a B6 
spleen graft being rejected by a control chimera.  By 3 wk 
iron deposits abound, the follicular structure has disappeared, 
and much of it has been replaced by fibrotic tissue. In con- 
trast, a syngeneic BALB/c graft accepted by an experimental 
B6 TS ~  BALB/c chimera (Fig. 7 C) maintains the general 
architecture  of a normal spleen with easily distinguishable 
red and white pulp. Fig. 7 D shows that the B6 spleen graft 
in the same chimera, though not yet completely destroyed, 
shows signs of rejection.  Iron deposits are visible, and the 
follicular structure is completely disrupted. 
Thus, we saw no discrepancy in the results of the different 
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Figure 6.  Chimeras reconstituted  with B6 TS re- 
spond to B6 spleen cells in vitro. Represented are the 
mixed lymphocyte (top) and cytotoxic reactions  (bottom) 
of four chimeric animals and a control BALB/c mouse 
to B6 (solid line), BALB/c (small dashes), and third-party 
AKK (large dashes) ceils. Data are shown as Acpm over 
backgrounds that varied from 5 to 20% of the specific 
response. CTL assays were done by the JAM Test. 
1157  Bonomo and Matzinger Figure 7.  Chimeras  reconstituted  with B6 "IS reject B6 spleen grafts  in vivo. (A) The state of B6 nude and BALB/c  nude spleen fragments  grafted 
under the kidney  capsules of chimeric mice 21 d after grafting. Hosts were B6 TS ~  BALB/c nude chimeras (right two kidneys) and BALB/c "IS 
BALB/c  nude  chimera  controls  (left two kidneys). Note that the B6 spleens  have  the same necrotic  appearance  in both control  and experimental  chimeras, 
while the BALB/c grafts remain  intact. (B-D) Thin sections of the grafts stained  with H & E. (B) Positive  control: B6 spleen grafted  into a BALB/c 
"IS ~  BALB/c  nude  chimera. (C) Negative  control:  BALB/c  spleen  grafted  into BALB/c TS --~ BALB/c  nude chimera. (D) Test graft:  B6 spleen  grafted 
into a B6 "IS ~  BALB/c nude chimera. 
assays. Whether we tested against skin or spleen, in vivo or 
in vitro, we found that BALB/c T cells that matured in B6 
TS were not tolerant of other B6 tissues,  through their re- 
sponses were less vigorous than those of normal BALB/c mice. 
B6 TS  Tolerizes  T  Cells Specific for B6  TS.  Two explana- 
tions existed for our results and those of others. Having found 
tolerance by in vivo tests and reactivity in vitro, Sprent and 
his colleagues (3, 4) proposed that TS induces an incomplete 
state of tolerance,  deleting only the highest affinity T  cells, 
and that the in vitro MLR can be mediated by cells with 
lower affinity than can GVH or skin graft rejection. Our 
finding, that unprimed chimeras reject spleen  grafts while 
only primed mice reject skin, could also be assimilated  into 
this picture if we postulated that memory T  cells are more 
easily stimulated than virgin cells, and that tail skin, having 
few strong APC, is an inefficient initiator of primary ira- 
mune responses. A second possibility was that the tolerance 
induced by TS is no different from the profound tolerance 
induced by bone marrow-derived cells, but that it influences 
only those T  cells specific for the TS surface MAP, leaving 
untouched any T  cells specific for antigens that are unique 
to the MAPs of skin or spleen  cells. 
To distinguish between these two possibilities,  we grafted 
our chimeras with a fresh fetal (day 15) B6 thymus. This second 
graft was not treated with deoxyguanosine so that its resi- 
dent APC population would act to stimulate a rejection re- 
sponse  (21, 28).  Because it had been suggested to us that a 
thymus may be poorly populated with APC and therefore, 
like tail skin, be insufficiently stimulatory to induce a rejec- 
tion crisis in unprimed chimeras, we used primed recipients 
that had previously rejected either B6 skin or spleen grafts. 
As controls for acceptance and rejection, we also grafted in- 
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thymus grafts. 15-d untreated B6 fetal thymuses 
were transplanted into B6 TS --~ BALB/c nude 
chimeras that had previously been primed with 
B6 spleen cells and had rejected B6 skin or spleen 
grafts (labeled 2). As positive and negative con- 
trols, the thymuses were also grafted into normal 
immunocompetent BALB/c  hosts (C)  or into 
BALB/c nude mice (NU). Here we show the state 
of the grafted thymuses after 4 d (a) and 8 d (b). 
We also show the state of the original graft of 
B6 TS in the test recipient (I) 4 d after grafting 
the second  thymus. 
tact B6 thymuses  into BALB/c nude and normal mice. At 
various times later we examined the thymuses macroscopi- 
cally and their T cell subpopulations  by FACS  |  analysis. We 
expected the highly primed chimeric recipients to reject the 
bone marrow components of the new thymus grafts.  The 
question was, in the midst of this rejection crisis, would the 
epithelium itself be accepted? Figs. 8, a and b, and Fig.  9 
show that it was. 
By macroscopic inspection 4 d after grafting, the B6 thymus 
grafted into a chimera (Fig. 8 a, 2) resembled the one being 
rejected by a normal immunocompetent BALB/c mouse (Fig. 
8 a, C). Both were bloody, and upon microscopic examina- 
tion showed a disruption of the stromal  architecture.  This 
indicates that the intact thymus contained enough strong APC 
to initiate a rapid and violent rejection crisis. In contrast, the 
chimera's original TS graft (Fig. 8 a, 1) had the same white, 
plump,  and healthy appearance as  the unrejected thymus 
grafted into a nude mouse (Fig. 8 a, NU). By day 8 (Fig. 
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8 b, 2), the appearance of the test  thymus had completely 
changed. Unlike the thymus grafted into a normal BALB/c 
(Fig. 8 b, C), it was now white, plump, and as healthy as 
the thymus grafted into a control nude mouse (Fig. 8 b, NL  0, 
suggesting that the rejection crisis had abated,  leaving the 
thymic epithelium apparently  intact. The chimeras rapidly 
rejected third-party AKR fetal thymus grafts (not shown), 
showing that their acceptance  of the B6 epithelium was specific 
and not due to a generalized inability to reject thymic epi- 
thelium. 
To see if the epithelial components of the thymus grafts 
had been fully accepted, we examined their functional state 
by analyzing the T cell populations  maturing within them. 
Fig. 9 shows the changes in total cell number and the relative 
proportion of various T cell subpopulations  (shown by the 
partitions in the pie representing each data point) in each 
thymus at different times after grafting.  Fig. 9, le~, shows 
the kinetics of uninterrupted development. B6 fetal thymuses cell 
number 
B6 ~,-  nude 
(reconstitution) 
10 5 
10 4  - 
i ....................  I ...........................  i 
B6--~  (B6--~  nude) 
(test) 
i .......................  I ...........................  i 
4  8  13 
d 
B6  --~ BALB/c 
(rejection) 
i .......................  I ...........................  i 
double 
[]  positive 
double 
[]  negative 
b 
[]  single H-2 
d 
￿9  single H-2 
Figure 9.  "IS-transplanted  chimeras reject the bone marrow but not the epithelial component of B6 thymuses. 15-d B6 fetal thymuses were trans- 
planted into B6 TS --- BALB/c nude chimeras, BALB/c nude mice, or normal immunocompetent BALB/c hosts as indicated, and analyzed on days 
4, 8, and 13. The graph shows the number of cells (shown by the position of each pie graph on the y-axis) and the relative proportions of various 
T cell subpopulations (by the sizes of the slices within each pie) within each thymus. The cells from the grafted thymuses were counted, stained with 
directly labeled mAbs specific for CD4, CDS, and either D  a or K  b, and analyzed in three colors. The data include the chimeras shown in Fig. 8, 
and represent are of a total of 12 chimeras and an equivalent number of controls analyzed up to day 13. Another 10 were analyzed at various times 
up to day 100. 
grafted into control BALB/c nude mice grew steadily over 
the next  13 d, reaching a size of -107 cells,  and continued 
to produce T  cells. In contrast,  Fig. 9, right, shows that B6 
thymuses were quickly rejected by normal immunocompe- 
tent BALB/c mice. At first they expanded slightly with an 
inrush  of mature host T  cells,  then declined in numbers as 
the rejection continued and had virtually disappeared by day 
13. B6 thymuses (Fig. 9, middle) grafted into primed chimeras 
seemed at first to be rejected, as their constitution  on day 
4 resembled that  of the rejected thymuses in BALB/c mice 
at day 8, yet they recovered by day 13 and were now on par, 
in both cell number and T cell subsets, with the unrejected 
thymuses in the nude recipients.  Between days 35 and 100 
these test thymuses remained functional, containing normal 
proportions of T  cell subpopulations, which,  when stained 
for H-2  d, resembled a normal BALB/c thymus (not shown). 
Thus, though the bone marrow component of the test thymus 
appeared to be rapidly rejected, the epithelium remained and 
continued to promote normal T cell development. From these 
results we concluded that  the B6 TS --,. BALB/c chimeras, 
though clearly capable of responding to most B6 tissues, were 
tolerant  of B6 thymic  stromal  cells. 
Conclusion.  Taken  together,  our  results  argue  that:  (a) 
thymic epithelium  expresses a surface MHC-peptide MAP 
that overlaps with but is not identical to the MAPs of other 
tissues.  (b) It induces tolerance to the antigens it expresses. 
The activity seen in vivo and in vitro against skin and bone 
marrow-derived cells is most likely due to T  cells directed 
against  skin-  and spleen-specific antigens  not contained  in 
the TS MAP.  (c) It can induce tolerance by deletion. 
Discussion 
MAPs and the Concept of Tissue-specific Tolerance.  It has 
been 15 yr since it was first proposed that reactivity against 
MHC antigens is actually directed against a plethora of MHC- 
antigen complexes (13) and,  though  the model has  gained 
acceptance,  its ramifications  have not yet been widely applied. 
One of them,  the concept of tissue-specific MAPs, is that 
each cell,  because of its unique function,  expresses  its own 
particular set of proteins and consequently its own particular 
signature of surface MHC-peptide complexes. We find that 
the notions of tissue-specific MAPs and MAP-specific toler- 
ance clear up a large set of otherwise confusing observations 
that  have been accumulating  for the last 40 yr. 
In 1952, Billingham et al. (29) attempted to use reciprocal 
skin grafts to distinguish between identical and fraternal bo- 
vine twins but found the task to be impossible. Because bo- 
vine twins share placental circulation and become reciprocal 
chimeras (reported 10 yr before by Owen et al.  [30]), both 
types of twins accepted each other's skin. Strangely though, 
some of the mutually tolerant  calves reacted differently to 
maternal  skin and this finding remained unexplained  until 
30 yr later,  when Emery and McCullagh  (31) repeated the 
experiments with flank rather than ear skin. With this more 
sensitive graft, they found that the twin calves were not fully 
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chimeras.  They concluded that tolerance of the MHC an- 
tigens of bone marrow does not extend completely to skin. 
Billingham and Silvers (17) ran into the same problem in 
a meticulous study on H-Y in which they injected A/J male 
cells into neonatal B6 females. These mice later accepted B6 
male skin grafts, showing that male A/J cells could tolerize 
for B6 male, but they rejected A/J skin. The authors won- 
dered how this "split tolerance" to H-Y could exist in the 
absence of tolerance to A/J, since persistent chimerism should 
be necessary for both. 15 yr later, Boyse et al. (32) discovered 
Sk, a skin-specific antigen difference between A/J and B6. 
Thus, Billingham and Silver's split tolerance can be explained 
as tissue-specific tolerance.  The B6 females were tolerant of 
A/J male hemopoietic cells but rejected A/J skin because of 
the Sk difference. 
Since then, >30 reports of tissue-specific antigens have ap- 
peared (33-37) and, with the concept of MAPs, may provide 
an explanation for three types of perplexing findings. The 
first is an experiment in which Gao et al. (3), to study the 
tolerizing capacity of TS, created twice-irradiated and twice 
bone  marrow-reconstituted  P1  -"  (P1  x  P2)  chimeras, 
reasoning that all host APC would be depleted by the irradi- 
ation and thus that P2 MHC class II molecules would re- 
main only on the TE. These animals did not react to P2 in 
vivo (to cause GVH death) nor in vitro (as CTL), though 
they did generate MLRs. The authors found this split toler- 
ance difficult to explain.  They considered and discarded the 
notion of tissue-specific tolerance,  arguing instead that the 
high affinity T  cells had been deleted, leaving low affinity 
T  cells that "for some reason" (3) could be activated  only 
in vitro. Using the concept of MAPs, we suggest the alterna- 
tive view that some of the in vivo tolerance they found was 
actually induced by tissues other than TE. For example, class 
II molecules are expressed by high endothelial venule (HEV) 
cells (38) and can be induced on many other tissues. Class 
I is expressed almost ubiquitously. The chimeric T cells were 
dearly unreactive to many radioresistant peripheral host tissues 
other than TS, and it is not surprising that they did not re- 
ject host type skin or cause GVH death in a second (also 
irradiated) host. 
The view that peripheral tissues may elicit tolerance of their 
own MAPs can also be used to explain other cases in which 
TS seemed to tolerize for skin. In the Xenopus test (9), the 
graft of thymic epithelium consisted of an entire head with 
its surrounding skin, and in mouse chimeras made with 10-d 
fetal thymus (8,  39),  the grafts consisted of pieces of em- 
bryonic somite, which contain the primordial cells for tra- 
cheal cartilage,  thyroid, and parathyroid (40). In "all of these 
studies the peripheral organs may have generated their own 
tolerance. 
The second group of experiments includes transgenic mice 
expressing allogeneic MHC molecules controlled by tissue- 
specific promoters (41), or mice grafted with APC-depleted 
allogeneic tissues  (42,  43),  that do not reject  the original 
MHC-bearing tissue but nevertheless respond when tested 
by in vitro assays. This form of split tolerance has been dis- 
cussed in terms of anergy,  suppression, networks, etc., but 
here also the concept of MAPs gives a clear picture in which 
T cell populations can be devoid of cells specific for a partic- 
ular tissue (e.g.,  class II on pancreatic  cells) and responsive 
to another (class II on spleen APC). In the case where pan- 
creatic  expression  of an MHC molecule induced tolerance 
in the thymus (44),  there may have been some thymic ex- 
pression and, in the case (45, 46) where addition of massive 
amounts oflymphokines  or other sources of help has "reversed" 
the tolerant state, we suggest that this allowed the activation 
of those few T  cells that had not yet traveled through the 
tolerizing organ. 
Tissue-specific MAPs may also explain why humans car- 
lying foreign organ grafts may still respond to the donor's 
APC by MLR, why tolerance induced by blood transfusions 
reduces but often does not completely abolish reactivity to 
a kidney (47), and why some autoimmune diseases show a 
distinct pattern of muhi-organ reactivity.  In fact,  in the 
majority of cases where a form of split tolerance  has been 
explained by anergy or suppressive interactions, a simpler ex- 
planation might be that the tolerance is simply tissue specific. 
Ontogeny of Toleranc~  In the thymus, immature developing 
T cells can be rendered tolerant by antigens presented by TE, 
by double-negative thymocytes (48), by mature CD8 T cells 
(49), as well as B cells (50, 51), islets (52), and dendritic cells 
(53, 54). The dendritic cells need not be specialized thymic 
dendritic cells since dendritic cells from the spleen, which 
are the most efficient activators  of mature T  cells, are also 
the most efficient tolerizers  of developing thymocytes (53). 
Thus it appears that a variety of tissues, including profes- 
sional  APC,  can  present  antigen  to  induce  tolerance  in 
maturing thymocytes, supporting our earlier suggestion that 
the decision between deletion and activation is not imposed 
by the environment, but is an intrinsic property of the de- 
veloping thymocyte itself (53). 
Generalizing from these results,  we postulate that toler- 
ance induction can occur in three distinct phases. The first, 
in the thymus, is the most stringent. Here developing thymo- 
cytes pass through a stage where tolerance is their inherent 
response to antigens presented by any cell, regardless of that 
cell's normal function (53, 55). This might be a stage in which 
the TCR is connected to internal apoptotic pathways but not 
yet to activating pathways (56, 57), or in which the thymo- 
cytes do not yet express receptors for any form of APC- or 
helper cell-derived second signals (42, 58), leaving them acutely 
susceptible to TCR-mediated death. Such a susceptibility step 
will eliminate those cells specific for antigens found on TE, 
T cells, perhaps CD5 + B cells, and dendritic cells (including 
antigens common to all cells, antigens specific to dendritic 
cells, and some peripheral antigens that have been picked up 
by dendritic cells). T  cells that pass through this stage un- 
scathed become mature and leave for the periphery. Here, 
as virgin cells, they enter a second phase in which they can 
be activated by professional APC but remain tolerizable  to 
antigens presented by other types of cells, such as B cells (59, 
60),  keratinocytes (61), thyroid (28),  normal or transgenic 
islets (41, 42), etc. Tolerance to the MAPs of peripheral tissues 
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There is also evidence for a third phase in which the need 
for signals from CD4 T helper cells creates a fail-safe mecha- 
nism (56) that maintains  tolerance in B cells (62) and both 
virgin  (63,  64)  and memory CTL  (64). 
Positive vs. Negative Selection.  If the tissue thought to be 
involved in positive selection also negatively selects, how do 
any T cells slip through the gauntlet? There are three possi- 
bilities.  It has been suggested several times that  there may 
be two different sorts of TS, one involved in positive selec- 
tion, and the other, perhaps expressing different peptides (5, 
12), in negative selection. The critical point is that the posi- 
tively selecting cell must not negatively select.  The data in 
Fig. 9 suggest that no such cell exists.  If there were an epi- 
thelial tissue able to positively but not negatively select, the 
B6 TS -" BALB/c nude chimeras would not be tolerant of 
it. When grafted with a second, intact B6 thymus, they would 
reject the positively selecting cell during  the violent rejec- 
tion crisis that occurs (Figs. 8, c and d, and 9), and the second 
thymus, having lost the positively selecting cells, would not 
be able to produce mature single-positive  T cells. Yet we found 
that,  when the second thymuses recovered from the rejec- 
tion of their hemopoietic passengers, they were repopulated 
with new stem cells and went on to support T cell develop- 
ment in a manner indistinguishable  from normal thymuses 
or those grafted into nude hosts. Thus they must have con- 
tained  the cells responsible for positive selection. 
Another proposal has been that the difference between posi- 
tive and negative selection is based on affinity; the immature 
T  cell is selected to live and continue its differentiation  if 
it binds with  low affinity to MHC molecules on TS,  and 
is told to die if its affinity for these same molecules is high. 
There  are several versions of this idea,  none of them fully 
satisfying, some suggesting that the distinction is due to the 
adhesion molecules involved, some by the level of TCR, and 
others by the stage of differentiation of the T cell (reviewed 
in references 65 and 66). 
A  third  possibility is that  the TE may be involved in a 
positive selection step that is not based on the specificity of 
the TCR. We envisage a selection step in which T  cells are 
screened, in the same manner as B cells, by an endogenous 
ligand somewhat like the postulated stromal element recog- 
nized by V pre-B (67, 68). The ligand would bind to con- 
served portions of the TCR/8 chain and also to MHC mole- 
cules on thymic stromal elements, allowing the coaggregation 
of MHC with the TCR. If the TCR is properly hooked up 
to CD3, CD4 or CD8, and internal signaling pathways, the 
crosslinking induced by the endogenous ligand generates the 
signal that allows the T  cell to continue development. The 
ligand,  which may be on the immature  T  cells themselves 
or on the stromal elements, thus probes each cell for the ex- 
pression of a properly rearranged  receptor that  is properly 
connected. After this step, autoreactive cells would be nega- 
tively selected by both TS and bone marrow-derived cells, 
leaving a functional, mostly self-tolerant and widely hetero- 
geneous T cell population to emigrate into the periphery (69). 
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